Pharmaceutical & Life Sciences

The Pharmaceutical and Life Sciences industry is taking a turn globally. And, these trends are as follows:

• Brand spending in the developed markets is being negatively affected by patent expirations, the number one winner is the Generics sector.
• The USA's share of drug spending dropped from 41% in 2006 to 31% in 2016, mainly because of patent expiries.
• The major turn in the R&D spenders - at present, the USA spends the most on R&D. But, according to the research and recent data, China may lead by 2020.